What was the overall market valuation of the UK generic pharmaceuticals market in 2024?

The overall market valuation was $16.42 Billion in 2024. Read More

What is the projected market valuation for the UK generic pharmaceuticals market by 2035?

The projected market valuation for 2035 is $38.5 Billion. Read More

What is the expected CAGR for the UK generic pharmaceuticals market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is 8.05%. Read More

Which therapeutic area had the highest valuation in the UK generic pharmaceuticals market in 2024?

In 2024, the therapeutic area of Infectious Diseases had the highest valuation at $5.12 Billion. Read More

What are the key players in the UK generic pharmaceuticals market?

Key players include Teva Pharmaceutical Industries, Sandoz, Mylan, and Sun Pharmaceutical Industries. Read More

What was the valuation of small molecule drugs in the UK generic pharmaceuticals market in 2024?

The valuation of small molecule drugs was $10.0 Billion in 2024. Read More

How much is the market for injectables projected to grow by 2035?

The market for injectables is projected to grow to $7.0 Billion by 2035. Read More

What was the valuation of the online pharmacy distribution channel in 2024?

The valuation of the online pharmacy distribution channel was $2.0 Billion in 2024. Read More

Which formulation type is expected to see the most growth by 2035?

Capsules are expected to grow to $9.0 Billion by 2035. Read More

What was the valuation of the cardiovascular diseases therapeutic area in 2024?

The valuation of the cardiovascular diseases therapeutic area was $2.5 Billion in 2024. Read More

UK Generic Pharmaceuticals Market

ID: MRFR/Pharma/43788-HCR

200 Pages

Nidhi Mandole

Last Updated: April 06, 2026

UK Generic Pharmaceuticals Market Research Report By Type (Simple Generics, Specialty Generics, Biosimilars), By Application (Central Nervous System Disorders, Respiratory Diseases, Hormones Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases, Cancer, Diabetes, Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others) and By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies) - Growth & Industry Forecast 2025 To 2035

UK Generic Pharmaceuticals Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Industrial Automation & Equipment, BY Type (USD Billion)
  1. 4.1.1 Small Molecule Drugs
  2. 4.1.2 Biologics
  3. 4.1.3 Biosimilars
2. 4.2 Industrial Automation & Equipment, BY Formulation Type (USD Billion)
  1. 4.2.1 Tablets
  2. 4.2.2 Injectables
  3. 4.2.3 Topicals
  4. 4.2.4 Capsules
  5. 4.2.5 Solutions
3. 4.3 Industrial Automation & Equipment, BY Therapeutic Area (USD Billion)
  1. 4.3.1 Cardiovascular Diseases
  2. 4.3.2 Diabetes
  3. 4.3.3 Cancer
  4. 4.3.4 CNS Disorders
  5. 4.3.5 Infectious Diseases
4. 4.4 Industrial Automation & Equipment, BY Distribution Channel (USD Billion)
  1. 4.4.1 Retail Pharmacy
  2. 4.4.2 Hospital Pharmacy
  3. 4.4.3 Online Pharmacy
  4. 4.4.4 Wholesalers
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Industrial Automation & Equipment
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Teva Pharmaceutical Industries (IL)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Sandoz (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Mylan (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Sun Pharmaceutical Industries (IN)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Aurobindo Pharma (IN)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Cipla (IN)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Lupin (IN)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Hikma Pharmaceuticals (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Amgen (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
  10. 5.2.10 Dr. Reddy's Laboratories (IN)
    1. 5.2.10.1 Financial Overview
    2. 5.2.10.2 Products Offered
    3. 5.2.10.3 Key Developments
    4. 5.2.10.4 SWOT Analysis
    5. 5.2.10.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY TYPE
3. 6.3 UK MARKET ANALYSIS BY FORMULATION TYPE
4. 6.4 UK MARKET ANALYSIS BY THERAPEUTIC AREA
5. 6.5 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6. 6.6 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT
9. 6.9 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
10. 6.10 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
11. 6.11 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT
12. 6.12 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE, 2024 (% SHARE)
13. 6.13 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE, 2024 TO 2035 (USD Billion)
14. 6.14 INDUSTRIAL AUTOMATION & EQUIPMENT, BY FORMULATION TYPE, 2024 (% SHARE)
15. 6.15 INDUSTRIAL AUTOMATION & EQUIPMENT, BY FORMULATION TYPE, 2024 TO 2035 (USD Billion)
16. 6.16 INDUSTRIAL AUTOMATION & EQUIPMENT, BY THERAPEUTIC AREA, 2024 (% SHARE)
17. 6.17 INDUSTRIAL AUTOMATION & EQUIPMENT, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Billion)
18. 6.18 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
19. 6.19 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY FORMULATION TYPE, 2025-2035 (USD Billion)
  3. 7.2.3 BY THERAPEUTIC AREA, 2025-2035 (USD Billion)
  4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Industrial Automation & Equipment Market Segmentation

Industrial Automation & Equipment By Type (USD Billion, 2025-2035)

Small Molecule Drugs
Biologics
Biosimilars

Industrial Automation & Equipment By Formulation Type (USD Billion, 2025-2035)

Tablets
Injectables
Topicals
Capsules
Solutions

Industrial Automation & Equipment By Therapeutic Area (USD Billion, 2025-2035)

Cardiovascular Diseases
Diabetes
Cancer
CNS Disorders
Infectious Diseases

Industrial Automation & Equipment By Distribution Channel (USD Billion, 2025-2035)

Retail Pharmacy
Hospital Pharmacy
Online Pharmacy
Wholesalers

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”